Subsequent Financing. From the date hereof until the date that is the twenty four (24) month anniversary of the Effective Date, the Company shall use its commercially reasonable efforts to, prior to any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents for cash consideration, or a combination of units thereof (a “Subsequent Financing”), provide each Purchaser with (x) written notice of the Subsequent Financing (including the contemplated terms and conditions of the Subsequent Financing, the amount of proceeds intended to be raised thereunder and the Person or Persons through or with whom such Subsequent Financing is proposed to be effected) and (y) the opportunity to consult reasonably with the Company with respect to the terms and conditions of such Subsequent Financing.
Subsequent Financing. During the period commencing on the Closing Date and expiring on the first to occur of (i) the twelve (12) month anniversary of the Effective Date of the Registration Statement or (ii) the twenty-four (24) month anniversary of the Closing Date, the Company will not, directly or indirectly, effect a subsequent financing (a “Subsequent Financing”) of its securities (whether structured as debt or equity), unless in each such case the Company shall have first offered to sell to the Subscribers in this Offering, in the aggregate, an amount of the securities offered in such Subsequent Financing equal to 50% of the securities offered in such Subsequent Financing (the securities to be offered to Subscribers pursuant to this Section being referred to herein in the “Offered Securities”). The Company shall offer to sell to each Subscriber (A) such Subscriber’s pro rata share of the Offered Securities (the “Basic Amount”), and (B) such additional portion of the Offered Securities as such Subscriber shall indicate it will purchase should the other Subscribers subscribe for less than their Basic Amounts (the “Undersubscription Amount”), at a price and on such other terms as shall have been specified by the Company in writing delivered to such Subscriber (the “Participation Notice”). The Company shall deliver the Participation Notice to the Subscribers at least 5 business days prior to the closing of the Subsequent Financing. Any Subscriber desiring to participate in such Subsequent Financing must provide written notice to the Company by not later than 5:30 p.m. (New York City time) on the 3rd business day following the date that the Company delivered such Participation Notice (the “Notice Period”) (calculated in accordance with the notice provisions set forth below in Section 7.7).
Subsequent Financing. The letter of intent dated June 10, 2002 between the Company and Commonwealth Associates, L.P. with respect to a $8 to $12 million subordinated note financing shall be in full force and effect.
Subsequent Financing. The Exercise Price per share may be adjusted, in Holder’s sole discretion, to equal 75% multiplied by the price per share in the next equity raise consummated by the Company.
Subsequent Financing. The Note is intended to provide necessary bridge financing to the Company prior to an anticipated financing in the near future of an amount up to $1,450,000 which is expected to be structured as convertible preferred stock (the "Preferred Financing"). Upon the closing of the Preferred Financing, the Note shall automatically convert into the Preferred Financing." We kindly request that you execute this letter below indicating that you agree with the above amendment. Sincerely, Boston Therapeutics Inc. By: /s/ Dxxxx Xxxxx Name: Dxxxx Xxxxx Title: CEO and Director AGREED AND ACKNOWLEDGED: CJY Holdings Limited By: /s/ Cxxxx Xxx Him Name: Cxxxx Xxx Him Title:
Subsequent Financing. The Note is intended to provide necessary bridge financing to the Company prior to an anticipated financing in the near future of an amount up to $1,702,000 which is expected to be structured as convertible preferred stock (the "Preferred Financing"). Upon the closing of the Preferred Financing, the Note shall automatically convert into the Preferred Financing." We kindly request that you execute this letter below indicating that you agree with the above amendment. Sincerely, Boston Therapeutics Inc. By: /s/ Cxxxxx Xxx-Xxxx Cheng Name: Cxxxxx Xxx-Xxxx Cheng Title: Interim CEO AGREED AND ACKNOWLEDGED: CJY Holdings Limited By: /s/ Cxxxx Xxx Him Name: Cxxxx Xxx Him Title:
Subsequent Financing. Borrower shall raise a minimum of $20,000,000 in gross cash proceeds through the sale of new equity or subordinated debt no later than January 31, 2014, $10,000,000 of which must be raised by Borrower no later than June 21, 2013.”
Subsequent Financing. After the Substantial Completion of the Project, Xxxxxxxx may elect to refinance, from time to time, all or portions the Project without any requirement to obtain the Proprietary Approval of Herndon. Notwithstanding the foregoing, all debt secured by a lien on the Condominium common elements and Herndon Components shall be released at the time of the Arts Center Closing. Herndon will reasonably cooperate with Xxxxxxxx with respect to such refinance(s) including by delivering any reasonable certification or estoppel requested by any Lender.
Subsequent Financing. Subsequent financing shall be consistent with the Proposal, and in the best interests of the Authority.
Subsequent Financing. The Company shall not have consummated a financing of its debt or equity securities.
